RLS Global investor relations material
Listen to the latest call from RLS Global
RLS Global AB, a medical technology company, develops and sells products for the treatment of illnesses in wound and oral care. It offers ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; CariSolv, a gel used for removing caries; and Urolift that is used to treat urinary incontinence in both men and women. The company was founded in 1996 and is based in Mölndal, Sweden
Ticker
RLSCountry
SEAbout
IR-page